Blog - Page 4789 of 5814 - BIOENGINEER.ORG

Credit: The New England Journal of Medicine The mutational burden, or the number of mutations present in a tumors DNA, ...

High out-of-pocket costs may place oral cancer medications out of reach

PHILADELPHIA - Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of ...

Fluorescent nanomedicine can guide tumor removal, kill remaining cancer cells

PORTLAND, Ore. - Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which ...

A repurposed drug could open door to more stem cell transplants

Credit: UBC/Paul Joseph A medication used to treat joint and skin conditions might also help people whose only hope of ...

After the diagnosis: How cancer affects sexual functioning

Credit: University of Houston A cancer diagnosis disrupts a person's life in many ways, including sexually. A study led by ...

Electron microscope images reveal how cells absorb a vital mineral

Credit: Credit: Sobolevsky lab/CUMC New York, NY (Dec. 20, 2017) -- Columbia University Medical Center (CUMC) researchers have obtained the ...

Molecular super enhancers: A new key for targeted therapy of brain cancer in children

Ependymoma refers to a heterogeneous group of cancers that can occur at any age and is one of the most ...

Low-dose X-ray exposure does not harm human stem cells

Credit: MIPT Press Office Biophysicists have shown that following low-dose exposure to X-rays (at 80 milligrays), stem cells remain healthy, ...

Smartphone app monitors cancer patients recovery

PITTSBURGH, Dec. 20, 2017 - Cancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm ...

Expensive new cancer therapy may be cost effective

AURORA, Colo. (Dec. 20, 2017) - Researchers from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, selected ...

Many brain tumor patients do not receive adequate end-of-life care

While more than 60 percent of patients with the brain tumors called malignant gliomas enroll in hospice services, almost a ...

Harnessing sperm to treat gynecological diseases

Credit: American Chemical Society Delivering drugs specifically to cancer cells is one approach researchers are taking to minimize treatment side ...

Results from Alliance CABOSUN trial lead to US FDA approval of extended indication

The Alliance for Clinical Trials in Oncology (the Alliance), in conjunction with industry partner Exelixis, today announced that the U.S. ...

Overlooked immune cells hold breakthrough for treating aggressive cancers

Credit: Medical University of South Carolina The latest generation of cancer treatments spring from the discovery that the human immune ...

NIH study uncovers clues about why common cancer drug causes hearing loss

Scientists have found a new way to explain the hearing loss caused by cisplatin, a powerful drug used to treat ...

Ludwig researchers uncover mechanism behind metabolic vulnerability of some breast cancers

Credit: Ludwig Cancer Research DECEMBER 19, 2017, New York -- Scientists have known since the 1980s that many cancer cells ...

DNA annotations predict patient outcomes in childhood leukemia

UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond ...

Novel combination therapy shown to be effective in ovarian cancer

PHILADELPHIA -- (Dec. 19, 2017) -- Researchers at The Wistar Institute have found that combining PARP inhibitors, recently approved for ...

Monocytes have many faces

Credit: © Foto: Barbara Frommann/Uni Bonn When the immune system mobilizes its troops, antigen-presenting cells play an important role. They ...

Discovery of unsuspected flexibility offers new pathway to cancer drug development